{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:20:12Z","timestamp":1792632012265,"version":"4.5.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,21]],"date-time":"2008-01-21T00:00:00Z","timestamp":1200873600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"},{"start":{"date-parts":[[2008,1,21]],"date-time":"2008-01-21T00:00:00Z","timestamp":1200873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>According to the Diagnostic and Statistical Manual of Mental Disorders, 4 out of the 10 leading causes of disability in the US and other developed countries are mental disorders. Major depression, bipolar disorder, schizophrenia, and obsessive compulsive disorder (OCD) are among the most common mental disorders that currently plague numerous countries and have varying incidence rates from 26 percent in America to 4 percent in China. Though some of this difference may be attributable to the manner in which individual healthcare providers diagnose mental disorders, this noticeable distribution can be also explained by studies which show that a lack of certain dietary nutrients contribute to the development of mental disorders. Notably, essential vitamins, minerals, and omega-3 fatty acids are often deficient in the general population in America and other developed countries; and are exceptionally deficient in patients suffering from mental disorders. Studies have shown that daily supplements of vital nutrients often effectively reduce patients' symptoms. Supplements that contain amino acids also reduce symptoms, because they are converted to neurotransmitters that alleviate depression and other mental disorders. Based on emerging scientific evidence, this form of nutritional supplement treatment may be appropriate for controlling major depression, bipolar disorder, schizophrenia and anxiety disorders, eating disorders, attention deficit disorder\/attention deficit hyperactivity disorder (ADD\/ADHD), addiction, and autism. The aim of this manuscript is to emphasize which dietary supplements can aid the treatment of the four most common mental disorders currently affecting America and other developed countries: major depression, bipolar disorder, schizophrenia, and obsessive compulsive disorder (OCD).<\/jats:p><jats:p>Most antidepressants and other prescription drugs cause severe side effects, which usually discourage patients from taking their medications. Such noncompliant patients who have mental disorders are at a higher risk for committing suicide or being institutionalized. One way for psychiatrists to overcome this noncompliance is to educate themselves about alternative or complementary nutritional treatments. Although in the cases of certain nutrients, further research needs to be done to determine the best recommended doses of most nutritional supplements, psychiatrists can recommend doses of dietary supplements based on previous and current efficacious studies and then adjust the doses based on the results obtained.<\/jats:p>","DOI":"10.1186\/1475-2891-7-2","type":"journal-article","created":{"date-parts":[[2008,1,22]],"date-time":"2008-01-22T07:14:35Z","timestamp":1200986075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":176,"title":["Nutritional therapies for mental disorders"],"prefix":"10.1186","volume":"7","author":[{"given":"Shaheen E","family":"Lakhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen F","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,21]]},"reference":[{"issue":"6","key":"165_CR1","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Chiu WT, Demler O, Walters EE: Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry. 2005, 62 (6): 617-627. 10.1001\/archpsyc.62.6.617.","journal-title":"Archives of General Psychiatry"},{"issue":"21","key":"165_CR2","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1001\/jama.291.21.2581","volume":"291","author":"K Demyttenaere","year":"2004","unstructured":"Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, Angermeyer MC, Bernert S, de Girolamo G, Morosini P, Polidori G, Kikkawa T, Kawakami N, Ono Y, Takeshima T, Uda H, Karam EG, Fayyad JA, Karam AN, Mneimneh ZN, Medina-Mora ME, Borges G, Lara C, de Graaf R, Ormel J, Gureje O, Shen Y, Huang Y, Zhang M, Alonso J, Haro JM, Vilagut G, Bromet EJ, Gluzman S, Webb C, Kessler RC, Merikangas KR, Anthony JC, Von Korff MR, Wang PS, Brugha TS, Aguilar-Gaxiola S, Lee S, Heeringa S, Pennell BE, Zaslavsky AM, Ustun TB, Chatterji S, WHO World Mental Health Survey Consortium: Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004, 291 (21): 2581-2590. 10.1001\/jama.291.21.2581.","journal-title":"JAMA"},{"key":"165_CR3","first-page":"270","volume-title":"World Health Organization","author":"CJL Murray","year":"1996","unstructured":"Murray CJL, Lopez AD: The Global Burden Of Disease. World Health Organization. 1996, 270-"},{"key":"165_CR4","volume-title":"Fourth edition, text revision Washington DC","author":"A American Psychiatric","year":"2000","unstructured":"American Psychiatric A: Diagnostic and Statistical Manual of Mental Disorders. Fourth edition, text revision Washington DC. 2000"},{"issue":"4","key":"165_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2165\/00139709-200625040-00003","volume":"25","author":"WS Waring","year":"2006","unstructured":"Waring WS: Management of lithium toxicity. Toxicol Rev. 2006, 25 (4): 221-230. 10.2165\/00139709-200625040-00003.","journal-title":"Toxicol Rev"},{"issue":"1","key":"165_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/15622970601083280","volume":"8","author":"E Vieta","year":"2007","unstructured":"Vieta E, Rosa AR: Evolving trends in the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2007, 8 (1): 4-11. 10.1080\/15622970601083280.","journal-title":"World J Biol Psychiatry"},{"issue":"2","key":"165_CR7","first-page":"205","volume":"166","author":"SN Young","year":"2002","unstructured":"Young SN: Clinical nutrition: 3. The fuzzy boundary between nutrition and psycopharmacology. CMAJ. 2002, 166 (2): 205-209.","journal-title":"CMAJ"},{"key":"165_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1749-6632.1989.tb53234.x","volume":"575","author":"R Wurtman","year":"1989","unstructured":"Wurtman R, O'Rourke D, Wurtman JJ: Nutrient imbalances in depressive disorders. Possible brain mechanisms. Ann N Y Acad Sci. 1989, 575: 75-82. 10.1111\/j.1749-6632.1989.tb53234.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"165_CR9","first-page":"80","volume":"32","author":"SN Young","year":"2007","unstructured":"Young SN: Folate and depression\u2013a neglected problem. J Psychiatry Neurosci. 2007, 32 (2): 80-82.","journal-title":"J Psychiatry Neurosci"},{"issue":"9110","key":"165_CR10","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/S0140-6736(05)79168-6","volume":"351","author":"JR Hibbeln","year":"1998","unstructured":"Hibbeln JR: Fish consumption and major depression. The Lancet. 1998, 351 (9110): 1213-10.1016\/S0140-6736(05)79168-6.","journal-title":"The Lancet"},{"issue":"9","key":"165_CR11","first-page":"837","volume":"16","author":"DO Rudin","year":"1981","unstructured":"Rudin DO: The major psychoses and neuroses as omega-3 essential fatty acid deficiency syndrome: substrate pellagra. Biol Psychiatry. 1981, 16 (9): 837-850.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"165_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0306-9877(82)90088-3","volume":"8","author":"DO Rudin","year":"1982","unstructured":"Rudin DO: The dominant diseases of modernized societies as omega-3 essential fatty acid deficiency syndrome: substrate beriberi. Med Hypotheses. 1982, 8 (1): 17-47. 10.1016\/0306-9877(82)90088-3.","journal-title":"Med Hypotheses"},{"issue":"3","key":"165_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1532-5415.1991.tb01646.x","volume":"39","author":"IR Bell","year":"1991","unstructured":"Bell IR, Edman JS, Morrow FD, Marby DW, Mirages S, Perrone G, Kayne HL, Cole JO: B complex vitamin patterns in geriatric and young adult inpatients with major depression. J Am Geriatr Soc. 1991, 39 (3): 252-257.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"165_CR14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.mehy.2006.01.047","volume":"67","author":"GA Eby","year":"2006","unstructured":"Eby GA, Eby KL: Rapid recovery from major depression using magnesium treatment. Med Hypotheses. 2006, 67 (2): 362-370. 10.1016\/j.mehy.2006.01.047.","journal-title":"Med Hypotheses"},{"key":"165_CR15","first-page":"1","volume":"3","author":"R Buist","year":"1983","unstructured":"Buist R: The therapeutic predictability of tryptophan and tyrosine in the treatment of depression. Int J Clin Nutr Rev. 1983, 3: 1-3.","journal-title":"Int J Clin Nutr Rev"},{"issue":"5","key":"165_CR16","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/0006-3223(85)90026-5","volume":"20","author":"G Chouinard","year":"1985","unstructured":"Chouinard G, Young SN, Annable L: A controlled clinical trial of L-tryptophan in acute mania. Biol Psychiatry. 1985, 20 (5): 546-547. 10.1016\/0006-3223(85)90026-5.","journal-title":"Biol Psychiatry"},{"issue":"4\u20135","key":"165_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.plefa.2006.07.014","volume":"75","author":"LC Reis","year":"2006","unstructured":"Reis LC, Hibbeln JR: Cultural symbolism of fish and the psychotropic properties of omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2006, 75 (4\u20135): 227-236. 10.1016\/j.plefa.2006.07.014.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"5","key":"165_CR18","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/archpsyc.58.5.512","volume":"58","author":"A Tanskanen","year":"2001","unstructured":"Tanskanen A, Hibbeln JR, Hintikka J, Haatainen K, Honkalampi K, Viinamaki H: Fish consumption, depression, and suicidality in a general population. Arch Gen Psychiatry. 2001, 58 (5): 512-513. 10.1001\/archpsyc.58.5.512.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"165_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2147\/vhrm.2006.2.3.251","volume":"2","author":"C von Schacky","year":"2006","unstructured":"von Schacky C: A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels. Vasc Health Risk Manag. 2006, 2 (3): 251-262. 10.2147\/vhrm.2006.2.3.251.","journal-title":"Vasc Health Risk Manag"},{"issue":"1 Suppl","key":"165_CR20","doi-asserted-by":"publisher","first-page":"197S","DOI":"10.1093\/ajcn\/71.1.197S","volume":"71","author":"J Eritsland","year":"2000","unstructured":"Eritsland J: Safety considerations of polyunsaturated fatty acids. Am J Clin Nutr. 2000, 71 (1 Suppl): 197S-201S.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"165_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/archpsyc.56.5.407","volume":"56","author":"AL Stoll","year":"1999","unstructured":"Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB: Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999, 56 (5): 407-412. 10.1001\/archpsyc.56.5.407.","journal-title":"Arch Gen Psychiatry"},{"key":"165_CR22","volume-title":"National Institute of Mental Health, National Institutes of Health","author":"National Institute of Mental Health","year":"2000","unstructured":"National Institute of Mental Health: Depression. National Institute of Mental Health, National Institutes of Health. 2000, US Department of Health and Human Services, Bethesda (MD) [Reprinted September 2002]."},{"issue":"8 Suppl","key":"165_CR23","first-page":"4","volume":"68","author":"AJ Rush","year":"2007","unstructured":"Rush AJ: The varied clinical presentations of major depressive disorder. The Journal of clinical psychiatry. 2007, 68 (8 Suppl): 4-10.","journal-title":"The Journal of clinical psychiatry"},{"key":"165_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1749-6632.1997.tb52362.x","volume":"836","author":"CA Stockmeier","year":"1997","unstructured":"Stockmeier CA: Neurobiology of serotonin in depression and suicide. Ann N Y Acad Sci. 1997, 836: 220-232. 10.1111\/j.1749-6632.1997.tb52362.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"165_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0165-0327(82)90025-8","volume":"4","author":"HM VanPraag","year":"1982","unstructured":"VanPraag HM: Depression, suicide and the metabolism of serotonin in the brain. J Affect Disord. 1982, 4 (4): 275-290. 10.1016\/0165-0327(82)90025-8.","journal-title":"J Affect Disord"},{"issue":"2","key":"165_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0010-440X(92)90007-D","volume":"33","author":"DJ Diehl","year":"1992","unstructured":"Diehl DJ, Gershon S: The role of dopamine in mood disorders. Compr Psychiatry. 1992, 33 (2): 115-120. 10.1016\/0010-440X(92)90007-D.","journal-title":"Compr Psychiatry"},{"key":"165_CR27","volume-title":"J Psychopharmacol","author":"C Firk","year":"2007","unstructured":"Firk C, Markus CR: Serotonin by stress interaction: a susceptibility factor for the development of depression?. J Psychopharmacol. 2007"},{"issue":"4 Suppl","key":"165_CR28","first-page":"S39","volume":"11","author":"BE Leonard","year":"1997","unstructured":"Leonard BE: The role of noradrenaline in depression: a review. J Psychopharmacol. 1997, 11 (4 Suppl): S39-S47.","journal-title":"J Psychopharmacol"},{"issue":"4","key":"165_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0165-0327(95)00025-I","volume":"34","author":"F Petty","year":"1995","unstructured":"Petty F: GABA and mood disorders: a brief review and hypothesis. J Affect Disord. 1995, 34 (4): 275-281. 10.1016\/0165-0327(95)00025-I.","journal-title":"J Affect Disord"},{"issue":"3","key":"165_CR30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s00213-003-1586-8","volume":"171","author":"A McLean","year":"2004","unstructured":"McLean A, Rubinsztein JS, Robbins TW, Sahakian BJ: The effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression. Psychopharmacology. 2004, 171 (3): 286-297. 10.1007\/s00213-003-1586-8.","journal-title":"Psychopharmacology"},{"issue":"1","key":"165_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0022-3956(76)90008-X","volume":"13","author":"A Agnoli","year":"1976","unstructured":"Agnoli A, Andreoli V, Casacchia M, Cerbo R: Effect of s-adenosyl-l-methionine (SAMe) upon depressive symptoms. J Psychiatr Res. 1976, 13 (1): 43-54. 10.1016\/0022-3956(76)90008-X.","journal-title":"J Psychiatr Res"},{"issue":"4","key":"165_CR32","first-page":"253","volume":"31","author":"M aan het Rot","year":"2006","unstructured":"aan het Rot M, Moskowitz DS, Pinard G, Young SN: Social behaviour and mood in everyday life: the effects of tryptophan in quarrelsome individuals. J Psychiatry Neurosci. 2006, 31 (4): 253-262.","journal-title":"J Psychiatry Neurosci"},{"key":"165_CR33","first-page":"231","volume":"4","author":"MJ Hoes","year":"1982","unstructured":"Hoes MJ: L-tryptophan in depression. Journal of Orthomolecular Psychiatry. 1982, 4: 231-","journal-title":"Journal of Orthomolecular Psychiatry"},{"issue":"1 Suppl","key":"165_CR34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1515\/jom-1984-840928","volume":"84","author":"HM Kravitz","year":"1984","unstructured":"Kravitz HM, Sabelli HC, Fawcett J: Dietary supplements of phenylalanine and other amino acid precursors of brain neuroamines in the treatment of depressive disorders. J Am Osteopath Assoc. 1984, 84 (1 Suppl): 119-123.","journal-title":"J Am Osteopath Assoc"},{"issue":"3","key":"165_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0306-9877(90)90097-X","volume":"31","author":"CP Maurizi","year":"1990","unstructured":"Maurizi CP: The therapeutic potential for tryptophan and melatonin: possible roles in depression, sleep, Alzheimer's disease and abnormal aging. Med Hypotheses. 1990, 31 (3): 233-242. 10.1016\/0306-9877(90)90097-X.","journal-title":"Med Hypotheses"},{"issue":"4","key":"165_CR36","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.mp.4001949","volume":"12","author":"HG Ruh\u00e9","year":"2007","unstructured":"Ruh\u00e9 HG, Mason NS, Schene AH: Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry. 2007, 12 (4): 331-359. 10.1038\/sj.mp.4001949.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"165_CR37","first-page":"865","volume":"41","author":"D DeLeo","year":"1987","unstructured":"DeLeo D: S-adenosylmethionine as an antidepressant: A double blind trial versus placebo. Curr Ther Res. 1987, 41 (6): 865-870.","journal-title":"Curr Ther Res"},{"issue":"3","key":"165_CR38","first-page":"306","volume":"25","author":"PG Janicak","year":"1988","unstructured":"Janicak PG, Lipinski J, Davis JM, Comaty JE, Waternaux C, Cohen B, Altman E, Sharma RP: S-adenosylmethionine in depression. A literature review and preliminary report. Ala J Med Sci. 1988, 25 (3): 306-313.","journal-title":"Ala J Med Sci"},{"issue":"Suppl","key":"165_CR39","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.1007\/BF02637069","volume":"31","author":"PB Adams","year":"1996","unstructured":"Adams PB, Lawson S, Sanigorski A, Sinclair AJ: Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids. 1996, 31 (Suppl): S157-S161. 10.1007\/BF02637069.","journal-title":"Lipids"},{"issue":"5","key":"165_CR40","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1378\/chest.97.5.1260","volume":"97","author":"BP Grubb","year":"1990","unstructured":"Grubb BP: Hypervitaminosis A following long-term use of high-dose fish oil supplements. Chest. 1990, 97 (5): 1260-10.1378\/chest.97.5.1260.","journal-title":"Chest"},{"issue":"4","key":"165_CR41","first-page":"288","volume":"21","author":"Z Rihmer","year":"2006","unstructured":"Rihmer Z, Gonda X, Rihmer A: Creativity and mental illness. Psychiatr Hung. 2006, 21 (4): 288-294.","journal-title":"Psychiatr Hung"},{"issue":"6","key":"165_CR42","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/0306-9877(81)90085-2","volume":"7","author":"GM Skutsch","year":"1981","unstructured":"Skutsch GM: Manic depression\u2013a disorder of central dopaminergic rhythm. Med Hypotheses. 1981, 7 (6): 737-746. 10.1016\/0306-9877(81)90085-2.","journal-title":"Med Hypotheses"},{"issue":"6","key":"165_CR43","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/0006-3223(85)90101-5","volume":"20","author":"GM Skutsch","year":"1985","unstructured":"Skutsch GM: Manic depression: a multiple hormone disorder?. Biol Psychiatry. 1985, 20 (6): 662-668. 10.1016\/0006-3223(85)90101-5.","journal-title":"Biol Psychiatry"},{"key":"165_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/026010608400300206","volume":"3","author":"GJ Naylor","year":"1984","unstructured":"Naylor GJ: Vanadium and manic depressive psychosis. Nutr Health. 1984, 3: 79-85.","journal-title":"Nutr Health"},{"key":"165_CR45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1017\/S0033291700052065","volume":"11","author":"GJ Naylor","year":"1981","unstructured":"Naylor GJ, Smith AH: Vanadium: a possible aetiological factor in manic depressive illness. Psychol Med. 1981, 11: 249-256.","journal-title":"Psychol Med"},{"key":"165_CR46","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1753-4887.1996.tb03851.x","volume":"54","author":"T Botiglieri","year":"1996","unstructured":"Botiglieri T: Folate, vitamin B12, and neuropsychiatric disorders. Nutr Rev. 1996, 54: 382-390.","journal-title":"Nutr Rev"},{"key":"165_CR47","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0165-0327(97)00096-7","volume":"46","author":"CI Hasanah","year":"1997","unstructured":"Hasanah CI, Khan UA, Musalmah M, Razali SM: Reduced red-cell folate in mania. J Affect Disord. 1997, 46: 95-99. 10.1016\/S0165-0327(97)00096-7.","journal-title":"J Affect Disord"},{"key":"165_CR48","first-page":"726","volume-title":"Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study","author":"Y Osher","year":"2005","unstructured":"Osher Y, Bersudsky Y, Belmaker RH: Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study. 2005, 66: 726-729."},{"issue":"6","key":"165_CR49","first-page":"407","volume":"14","author":"HA Nieper","year":"1973","unstructured":"Nieper HA: The clinical applications of lithium orotate. A two years study. Agressologie. 1973, 14 (6): 407-411.","journal-title":"Agressologie"},{"issue":"2","key":"165_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0741-8329(86)90018-2","volume":"3","author":"HE Sartori","year":"1986","unstructured":"Sartori HE: Lithium orotate in the treatment of alcoholism and related conditions. Alcohol. 1986, 3 (2): 97-100. 10.1016\/0741-8329(86)90018-2.","journal-title":"Alcohol"},{"issue":"4","key":"165_CR51","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0924-977X(03)00070-1","volume":"13","author":"T O'Donnell","year":"2003","unstructured":"O'Donnell T, Rotzinger S, Ulrich M, Hanstock CC, Nakashima TT, Silverstone PH: Effects of chronic lithium and sodium valproate on concentrations of brain amino acids. Eur Neuropsychopharmacol. 2003, 13 (4): 220-227. 10.1016\/S0924-977X(03)00070-1.","journal-title":"Eur Neuropsychopharmacol"},{"key":"165_CR52","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1192\/bjp.159.6.790","volume":"159","author":"E Castle","year":"1991","unstructured":"Castle E, Wessely S, Der G, Murray RM: The incidence of operationally defined schizophrenia in Camberwell 1965\u201384. British Journal of Psychiatry. 1991, 159: 790-794.","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"165_CR53","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00702-004-0200-5","volume":"112","author":"DFFMMA van der Heijden","year":"2005","unstructured":"van der Heijden DFFMMA, Tuinier S, Sijben AES, Kahn RS, Verhoeven WMA: Amino acids in schizophrenia: evidence for lower tryptophan availability during treatment with atypical antipsychotics?. Journal of Neural Transmission. 2005, 112 (4): 577-585. 10.1007\/s00702-004-0200-5.","journal-title":"Journal of Neural Transmission"},{"issue":"8","key":"165_CR54","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1176\/ajp.151.8.1234","volume":"151","author":"DC Javitt","year":"1994","unstructured":"Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer JP: Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry. 1994, 151 (8): 1234-1236.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"165_CR55","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0006-3223(95)00585-4","volume":"39","author":"E Leiderman","year":"1996","unstructured":"Leiderman E, Zylberman I, Zukin SR, Cooper TB, Javitt DC: Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial. Biol Psychiatry. 1996, 39 (3): 213-215. 10.1016\/0006-3223(95)00585-4.","journal-title":"Biol Psychiatry"},{"issue":"4","key":"165_CR56","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1017\/S1461145701002590","volume":"4","author":"DC Javitt","year":"2001","unstructured":"Javitt DC, Silipo G, Cienfuegos A, Shelley AM, Bark N, Park M, Lindenmayer JP, Suckow R, Zukin SR: Adjunctive high-dose glycine in the treatment of schizophrenia. Int J Neuropsychopharmacol. 2001, 4 (4): 385-391.","journal-title":"Int J Neuropsychopharmacol"},{"key":"165_CR57","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1192\/bjp.184.5.404","volume":"184","author":"M Peet","year":"2004","unstructured":"Peet M: International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis. British Journal of Psychiatry. 2004, 184: 404-408. 10.1192\/bjp.184.5.404.","journal-title":"British Journal of Psychiatry"},{"issue":"5","key":"165_CR58","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1600-0447.1988.tb06388.x","volume":"78","author":"O Christensen","year":"1988","unstructured":"Christensen O, Christensen E: Fat consumption and schizophrenia. Acta Psychiatr Scand. 1988, 78 (5): 587-591. 10.1111\/j.1600-0447.1988.tb06388.x.","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"165_CR59","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.plefa.2003.08.020","volume":"69","author":"M Peet","year":"2003","unstructured":"Peet M: Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results. Prostaglandins Leukot Essent Fatty Acids. 2003, 69 (6): 477-485. 10.1016\/j.plefa.2003.08.020.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"9","key":"165_CR60","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1176\/appi.ajp.159.9.1596","volume":"159","author":"R Emsley","year":"2002","unstructured":"Emsley R, Myburgh C, Oosthuizen P, van Rensburg SJ: Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia. Am J Psychiatry. 2002, 159 (9): 1596-1598. 10.1176\/appi.ajp.159.9.1596.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"165_CR61","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1742-1241.2000.tb11844.x","volume":"54","author":"BK Puri","year":"2000","unstructured":"Puri BK, Richardson AJ, Horrobin DF, Easton T, Saeed N, Oatridge A, Hajnal JV, Bydder GM: Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes. Int J Clin Pract. 2000, 54 (1): 57-63.","journal-title":"Int J Clin Pract"},{"issue":"3","key":"165_CR62","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0167-8760(99)00090-2","volume":"34","author":"AJ Richardson","year":"1999","unstructured":"Richardson AJ, Easton T, Gruzelier JH, Puri BK: Laterality changes accompanying symptom remission in schizophrenia following treatment with eicosapentaenoic acid. Int J Psychophysiol. 1999, 34 (3): 333-339. 10.1016\/S0167-8760(99)00090-2.","journal-title":"Int J Psychophysiol"},{"issue":"3","key":"165_CR63","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0924-977X(00)00068-7","volume":"10","author":"AJ Richardson","year":"2000","unstructured":"Richardson AJ, Easton T, Puri BK: Red cell and plasma fatty acid changes accompanying symptom remission in a patient with schizophrenia treated with eicosapentaenoic acid. Eur Neuropsychopharmacol. 2000, 10 (3): 189-193. 10.1016\/S0924-977X(00)00068-7.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"165_CR64","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1080\/11026480310007944","volume":"47","author":"AJ Richardson","year":"2003","unstructured":"Richardson AJ: The role of omega 3 fatty acids in behaviour, cognition and mood. Scandinavian Journal of Nutrition. 2003, 47 (2): 92-98. 10.1080\/11026480310007944.","journal-title":"Scandinavian Journal of Nutrition"},{"issue":"3","key":"165_CR65","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.plefa.2004.03.011","volume":"71","author":"JK Yao","year":"2004","unstructured":"Yao JK, Magan S, Sonel AF, Gurklis JA, Sanders R, Reddy RD: Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia. Prostaglandins Leukot Essent Fatty Acids. 2004, 71 (3): 171-176. 10.1016\/j.plefa.2004.03.011.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"165_CR66","volume-title":"Arlington, VA","author":"A American Psychiatric","year":"2000","unstructured":"American Psychiatric A: Quick Reference to the Diagnostic Criteria from DSM-IV-TR. Arlington, VA. 2000"},{"issue":"5","key":"165_CR67","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1517\/14656566.8.5.563","volume":"8","author":"LF Fontenelle","year":"2007","unstructured":"Fontenelle LF, Nascimento AL, Mendlowicz MV, Shavitt RG, Versiani M: An update on the pharmacological treatment of obsessive-compulsive disorder. Expert Opin Pharmacother. 2007, 8 (5): 563-583. 10.1517\/14656566.8.5.563.","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"165_CR68","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1176\/ajp.134.11.1298","volume":"134","author":"JA Yaryura-Tobias","year":"1977","unstructured":"Yaryura-Tobias JA, Bhagavan HN: L-tryptophan in obsessive-compulsive disorders. Am J Psychiatry. 1977, 134 (11): 1298-1299.","journal-title":"Am J Psychiatry"},{"issue":"7494","key":"165_CR69","first-page":"759","volume":"330","author":"A Szegedi","year":"2005","unstructured":"Szegedi A, Kohnen R, Dienel A, Kieser M: Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine. British Medical Journal. 2005, 330 (7494): 759-","journal-title":"British Medical Journal"},{"issue":"5","key":"165_CR70","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/01.jcp.0000178416.60426.29","volume":"25","author":"M Fava","year":"2005","unstructured":"Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF: A double-blind, randomized trial of St. John's wort, fluoxetine, and placebo in major depressive disorder. J Clin Psychopharmacol. 2005, 25 (5): 441-447. 10.1097\/01.jcp.0000178416.60426.29.","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"165_CR71","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0006-3223(90)90642-F","volume":"27","author":"IR Bell","year":"1990","unstructured":"Bell IR, Edman JS, Marby DW, Satlin A, Dreier T, Liptzin B, Cole JO: Vitamin B12 and folate status in acute geropsychiatric inpatients: affective and cognitive characteristics of a vitamin nondeficient population. Biol Psychiatr. 1990, 27 (2): 125-137. 10.1016\/0006-3223(90)90642-F.","journal-title":"Biol Psychiatr"},{"key":"165_CR72","first-page":"67","volume":"10","author":"AR Green","year":"1983","unstructured":"Green AR, Aronson JK: The pharmacokinetics of oral L-tryptophan: effects of dose and concomitant pyridoxine, allopurinol or nicotinamide administration. Adv Biol Psychiatr. 1983, 10: 67-81.","journal-title":"Adv Biol Psychiatr"},{"key":"165_CR73","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1176\/ajp.139.9.1162","volume":"139","author":"BM Cohen","year":"1982","unstructured":"Cohen BM, Lipinski JF, Altesman RI: Lecithin in the treatment of mania: double-blind, placebo-controlled trials. Am J Psychiatr. 1982, 139: 1162-1164.","journal-title":"Am J Psychiatr"},{"issue":"6\u20137","key":"165_CR74","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.euroneuro.2006.11.006","volume":"17","author":"J Wozniak","year":"2007","unstructured":"Wozniak J, Biederman J, Mick E, Waxmonsky J, Hantsoo L, Best C, Cluette-Brown JE, Laposata M: Omega-3 fatty acid monotherapy for pediatric bipolar disorder: A prospective open-label trial. Eur Neuropsychopharmacol. 2007, 17 (6\u20137): 440-447. 10.1016\/j.euroneuro.2006.11.006.","journal-title":"Eur Neuropsychopharmacol"},{"key":"165_CR75","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1192\/bjp.188.1.46","volume":"188","author":"S Frangou","year":"2006","unstructured":"Frangou S, Lewis M, McCrone P: Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomized double-blind placebo-controlled study. Br J Psychiatry. 2006, 188: 46-50. 10.1192\/bjp.188.1.46.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"165_CR76","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1017\/S0033291700023631","volume":"15","author":"K Rix","year":"1985","unstructured":"Rix K, Ditchfield J, Freed DL, Goldberg DP, Hillier VF: Food antibodies in acute psychoses. Psychol Med. 1985, 15 (2): 347-354.","journal-title":"Psychol Med"},{"key":"165_CR77","first-page":"403","volume-title":"London, Pan Books","author":"S Davies","year":"1987","unstructured":"Davies S, Stewart A: Nutritional Medicine. London, Pan Books. 1987, 403-"},{"key":"165_CR78","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0165-0327(91)90071-Y","volume":"22","author":"L Tondo","year":"1991","unstructured":"Tondo L, Rudas N: Course of seasonal bipolar disorder influenced by caffeine. J Affective Disorder. 1991, 22: 249-251. 10.1016\/0165-0327(91)90071-Y.","journal-title":"J Affective Disorder"},{"key":"165_CR79","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0924-9338(96)80461-5","volume":"11","author":"P Castrogiovanni","year":"1996","unstructured":"Castrogiovanni P, Pieraccini F: Dietary interferences with lithium therapy. Eur Psychiatr. 1996, 11: 53-54. 10.1016\/0924-9338(96)80461-5.","journal-title":"Eur Psychiatr"},{"key":"165_CR80","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1749-6632.1990.tb28058.x","volume":"585","author":"AL Bernstein","year":"1990","unstructured":"Bernstein AL: Vitamin B6 in clinical neurology. Annal NY Acad Sci. 1990, 585: 250-260. 10.1111\/j.1749-6632.1990.tb28058.x.","journal-title":"Annal NY Acad Sci"},{"key":"165_CR81","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.0954-6820.1965.tb01879.x","volume":"177","author":"E Edwin","year":"1965","unstructured":"Edwin E, Holten K, Norum FR, Schrumpf A, Skaug OE: Vitamin B12 hypovitaminosis in mental diseases. Acta Med Scand. 1965, 177: 689-699.","journal-title":"Acta Med Scand"},{"issue":"12","key":"165_CR82","doi-asserted-by":"publisher","first-page":"933","DOI":"10.4088\/JCP.v62n1203","volume":"62","author":"CW Popper","year":"2001","unstructured":"Popper CW: Do vitamins or minerals (apart from lithium) have mood-stabilizing effects?. J Clin Psychiatry. 2001, 62 (12): 933-944.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"165_CR83","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-0447.1969.tb06198.x","volume":"45","author":"T Haellstroem","year":"1969","unstructured":"Haellstroem T: Serum B12 and folate concentrations in mental patients. Acta Psychiatr Scand. 1969, 45 (1): 19-36. 10.1111\/j.1600-0447.1969.tb06198.x.","journal-title":"Acta Psychiatr Scand"},{"key":"165_CR84","first-page":"447","volume":"37C","author":"CJ Schorah","year":"1983","unstructured":"Schorah CJ, Morgan DB, Hullin RP: Vitamin C concentrations in patients in a psychiatric hospital. Hum Nutr Clin Nutr. 1983, 37C: 447-452.","journal-title":"Hum Nutr Clin Nutr"},{"key":"165_CR85","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1192\/bjp.109.459.294","volume":"109","author":"G Milner","year":"1963","unstructured":"Milner G: Ascorbic acid in chronic psychiatric patients: a controlled trial. Br J Psychiatr. 1963, 109: 294-299.","journal-title":"Br J Psychiatr"},{"issue":"2","key":"165_CR86","first-page":"3","volume":"12","author":"B Rimland","year":"1998","unstructured":"Rimland B: Plasma vitamin C in the prevention and treatment of autism. Autism Res Rev Intl. 1998, 12 (2): 3-","journal-title":"Autism Res Rev Intl"},{"issue":"11","key":"165_CR87","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jnutbio.2006.02.001","volume":"17","author":"FAJ Muskiet","year":"2006","unstructured":"Muskiet FAJ, Kemperman RFJ: Folate and long-chain polyunsaturated fatty acids in psychiatric disease. J Nutr Biochem. 2006, 17 (11): 717-727. 10.1016\/j.jnutbio.2006.02.001.","journal-title":"J Nutr Biochem"},{"issue":"7442","key":"165_CR88","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/bmj.328.7442.768-c","volume":"328","author":"MJ Taylor","year":"2004","unstructured":"Taylor MJ, Geddes J: Folic acid as ultimate in disease prevention: Folate also improves mental health. BMJ. 2004, 328 (7442): 768-769. 10.1136\/bmj.328.7442.768-c.","journal-title":"BMJ"},{"key":"165_CR89","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1176\/ajp.137.2.242","volume":"137","author":"BM Cohen","year":"1980","unstructured":"Cohen BM, Miller AL, Lipinski JF, Pope HG: Lecithin in mania: a preliminary report. Am J Psychiatr. 1980, 137: 242-243.","journal-title":"Am J Psychiatr"},{"issue":"6","key":"165_CR90","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1176\/ajp.2006.163.6.969","volume":"163","author":"G Parker","year":"2006","unstructured":"Parker G, Gibson NA, Brotchie H, Heruc G, Rees AM, Hadzi-Pavlovic D: Omega-3 fatty acids and mood disorders. Am J Psychiatry. 2006, 163 (6): 969-978. 10.1176\/appi.ajp.163.6.969.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"165_CR91","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1176\/appi.ajp.161.3.567","volume":"161","author":"R Hakkarainen","year":"2004","unstructured":"Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, L\u00f6nnqvist J: Is low dietary intake of omega-3 fatty acids associated with depression?. Am J Psychiatry. 2004, 161 (3): 567-569. 10.1176\/appi.ajp.161.3.567.","journal-title":"Am J Psychiatry"},{"key":"165_CR92","unstructured":"International medical news group: Depression linked to lower omega-3 fatty acid levels. Family Practice news. 2004, 34 (8): 54(51)"},{"issue":"Suppl","key":"165_CR93","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1007\/s11745-001-0691-y","volume":"36","author":"A Leaf","year":"2001","unstructured":"Leaf A: The electrophysiologic basis for the antiarrhythmic and anticonvulsant effects of n-3 polyunsaturated fatty acids: heart and brain. Lipids. 2001, 36 (Suppl): S107-110. 10.1007\/s11745-001-0691-y.","journal-title":"Lipids"},{"key":"165_CR94","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0161-4630(80)90022-1","volume":"4","author":"J Lieb","year":"1980","unstructured":"Lieb J: Linoleic acid in the treatment of lithium toxicity and familial tremor. Prostaglandins Med. 1980, 4: 275-279. 10.1016\/0161-4630(80)90022-1.","journal-title":"Prostaglandins Med"},{"issue":"2","key":"165_CR95","first-page":"66","volume":"47","author":"HC Sabelli","year":"1986","unstructured":"Sabelli HC, Fawcett J, Gusovsky F, Javaid JL, Wynn P, Edwards J, Jeffriess H, Kravitz H: Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements. J Clin Psychiatry. 1986, 47 (2): 66-70.","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"165_CR96","first-page":"355","volume":"46","author":"M Simonson","year":"1985","unstructured":"Simonson M: L-phenylalanine. J Clin Psychiatry. 1985, 46 (8): 355-","journal-title":"J Clin Psychiatry"},{"key":"165_CR97","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archpsyc.55.1.33","volume":"55","author":"F Bellivier","year":"1998","unstructured":"Bellivier F, Leboyer M, Courtet P, Buresi C, Beaufils B, Samolyk D, Allilaire JF, Feindgold J, Mallet J, Malafosse A: Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiatr. 1998, 55: 33-37. 10.1001\/archpsyc.55.1.33.","journal-title":"Arch Gen Psychiatr"},{"key":"165_CR98","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0006-3223(97)00010-3","volume":"43","author":"F Cassidy","year":"1998","unstructured":"Cassidy F, Murry E, Carroll BJ: Tryptophan depletion in recently manic patients treated with lithium. Biol Psychiatr. 1998, 43: 230-232. 10.1016\/S0006-3223(97)00010-3.","journal-title":"Biol Psychiatr"},{"key":"165_CR99","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1001\/archpsyc.1995.03950140072010","volume":"52","author":"C Benkelfat","year":"1995","unstructured":"Benkelfat C, Seletti B, Palmour RM, Hillel J, Ellenbogen M, Young SN: Tryptophan depletion in stable lithium-treated patients with bipolar disorder in remission. Arch Gen Psychiatry. 1995, 52: 154-155.","journal-title":"Arch Gen Psychiatry"},{"key":"165_CR100","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3109\/00207459208994781","volume":"67","author":"R Sandyk","year":"1992","unstructured":"Sandyk R: L-tryptophan in neuropsychiatric disorders: a review. Intl J Neurosci. 1992, 67: 127-144.","journal-title":"Intl J Neurosci"},{"key":"165_CR101","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1192\/bjp.154.1.48","volume":"154","author":"MWP Carney","year":"1989","unstructured":"Carney MWP, Chary TK, Bottiqlieri T, Reynolds EH: The switch mechanism and the bipolar\/unipolar dichotomy. Br J Psychiatr. 1989, 154: 48-51.","journal-title":"Br J Psychiatr"},{"issue":"4","key":"165_CR102","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0278-5846(88)90108-X","volume":"12","author":"LC Tolbert","year":"1988","unstructured":"Tolbert LC, Monti A, Walter-Ryan W, Alacron RD, Bahar B, Keriotis JT, Allison JG, Cates A, Antun F, Smythies JR: Clinical correlations of one-carbon metabolism abnormalities. Prog Neuropsychopharmacol Biol Psychiatr. 1988, 12 (4): 491-502. 10.1016\/0278-5846(88)90108-X.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatr"},{"issue":"3","key":"165_CR103","first-page":"316","volume":"25","author":"MWP Carney","year":"1988","unstructured":"Carney MWP, Chavy TK, Bottiglieri T, Reynolds LH: Switch and S-adenosylmethionine. Ala J Med Sci. 1988, 25 (3): 316-319.","journal-title":"Ala J Med Sci"},{"key":"165_CR104","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1006\/frne.2000.0202","volume":"22","author":"C Pacchierotti","year":"2001","unstructured":"Pacchierotti C, Iapichino S, Bossini L, Pieraccini F, Castrogiovanni P: Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry. Front Neuroendocrinol. 2001, 22: 18-32. 10.1006\/frne.2000.0202.","journal-title":"Front Neuroendocrinol"},{"key":"165_CR105","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1001\/archpsyc.57.6.572","volume":"57","author":"JI Nurnberger","year":"2000","unstructured":"Nurnberger JI, Adkins S, Lahiri DK, Mayeda A, Hu K, Lewy A, Miller A, Bowman ES, Miller MJ, Rau L, Smiley C, Davis-Singh D: Melatonin suppression by light in euthymic bipolar and unipolar patients. Arch Gen Psychiatry. 2000, 57: 572-579. 10.1001\/archpsyc.57.6.572.","journal-title":"Arch Gen Psychiatry"},{"key":"165_CR106","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3109\/07853899808999394","volume":"30","author":"D Avery","year":"1998","unstructured":"Avery D, Lenz M, Landis C: Guidelines for prescribing melatonin. Ann Med. 1998, 30: 122-130.","journal-title":"Ann Med"},{"key":"165_CR107","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0165-1781(94)90043-4","volume":"51","author":"D Fekkes","year":"1994","unstructured":"Fekkes D, Pepplinkhuizen L, Verheij R, Bruinvels J: Abnormal plasma levels of serine, methionine and taurine in transient, acute, polymorphic psychosis. Psychiatry Res. 1994, 51: 11-18. 10.1016\/0165-1781(94)90043-4.","journal-title":"Psychiatry Res"}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2891-7-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1475-2891-7-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2891-7-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2891-7-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:19:43Z","timestamp":1684196383000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionj.biomedcentral.com\/articles\/10.1186\/1475-2891-7-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,21]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["165"],"URL":"https:\/\/doi.org\/10.1186\/1475-2891-7-2","relation":{},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,21]]},"assertion":[{"value":"28 July 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}